Shots: The company has launched the first virtual clinic to guide patients with chronic conditions and helps to improve health and behavior via tracking tools & informational guides for weight management, daily activity levels and more Omada’s platform uses AI to analyze movements and range of motion via video and offers physical therapy sessions, wearable […]Read More
Shots: Medtronic launches a new insulin infusion set that can be worn for up to 7days. The infusion set is compatible with all MiniMed 600 and 700 series insulin pumps The extended infusion set utilizes advanced materials that help in reducing insulin preservative loss and maintains its flow & stability. The new tubing connector improves […]Read More
Shots: Roche launches Elecsys EBV immunoassay panel in countries accepting the CE mark. The Elecsys EBV panel consists of three immunoassays: Elecsys EBV IgM, Elecsys EBV VCA IgG, and Elecsys EBV EBNA IgG to detect Abs specific for the infection stage The Elecsys EBV panel accurately identifies the EBV infection stage from a single blood […]Read More
Shots: Roche launches eight new configurations for Cobas pro integrated solutions in countries accepting the CE mark and is designed to address the individual needs to maximize throughput and efficiency Cobas pro integrated solutions can deliver up to 4,400 tests/ hr., doubling its previous testing capacity. The addition of the new configurations allows labs to […]Read More
Shots: The new peptide MAM workflow for the BioAccord LC-MS system that helps to monitor critical quality attributes of protein-based drugs that can affect the safety & efficacy of innovator drugs and biosimilars By integrating BioAccord system on the waters_connect platform, scientists have a sensitive multiplexed method to accurately assess the attributes of protein-based drugs […]Read More
Shots: The coalition builds on Abbott’s excellence in virus surveillance and aid in analyzing virus samples for unknown diseases and detects mutations and variants including COVID-19 The goal of the Pandemic Defense Coalition is to identify new pathogens, analyze potential risk level, assess public health impact in real-time, and contain outbreaks when new virus threats […]Read More
Shots: The US FDA has approved NeuroSphere Virtual Clinic that allows a patient to communicate with a physician and remotely receive stimulation settings in real-time regardless of location NeuroSphere Virtual Clinic allows clinicians to provide new treatment settings remotely to the patient’s neurostimulation device using the clinician programmer app The virtual clinic is compatible with […]Read More
Shots: Health Canada has authorized Idacio on Oct 30, 2020, for marketing in Canada and is now available for all indications of the reference (Humira) in the field of rheumatology, gastroenterology and dermatology Health Canada’s approval was based on analytical, pre/ clinical data that demonstrated similar PK, efficacy, safety and immunogenicity to the Humira. Idacio […]Read More
Shots: Health Canada has approved Hulio, a biosimilar referencing AbbVie’s Humira (adalimumab), which is now available in Canada. It is licensed from Fujifilm Kyowa Kirin and approved for all adalimumab indications The approval was based on an analytical, pre/ clinical program. Fujifilm Kyowa Kirin conducted a P-III ARABESC study that demonstrated no differences in terms […]Read More
Shots: The company has launched Guardant Reveal liquid biopsy test for the detection of residual and recurrent disease from a simple blood draw to monitor CRC patients with 7-day turnaround time, residual disease after surgery and recurrence mos. earlier than current SoC methods like CEA tests or imaging The test can deliver industry leading sensitivity […]Read More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
